In this episode of Talking DTC with Bob Ehrlich, our founder and chairman and panelists will discuss the potential lasting effects of COVID on DTC marketing. How are patients, brands, and teams adapting to our new normal?

In this episode of Talking DTC with Bob Ehrlich, our founder and chairman and panelists will discuss the personalization of streaming, addressable, and the fragmentation of targeted media options. What can DTC marketers do to improve media selection and get better ROI?

COVID-19 showed us the need to be able to perform clinical trials faster and in a more patient friendly manner. This panel discusses new ways to recruit for clinical trials, including getting a representative group of participants; reaching out to potential participants outside of the doctor’s office; and how to increase the overall amount of people in the clinical trial system. Different ways of recruiting potential participants for clinical trials, the impact of decentralized clinical trials, and how we can use technology to better increase participation in clinical trials will be discussed. This panel is a preview of the half-day on Clinical Trial Marketing and Recruitment that will take place at this year’s Xpectives.Health Summit in April in Boston.

In this episode of Talking DTC with Bob Ehrlich, our founder and chairman and panelists will discuss what has changed at the office and pharmacy. Is POC poised to take a major share of spending?

With the importance of communicating health information to multicultural communities now more prominent than ever following the Covid crises, its very important that marketers learn to communicate with these communities in ways that are salient to them. This panel of experts discusses how to do so in a culturally competent manner and is a preview of the sorts of conversations and topics coming to the Multicultural Health National Conference next month

In this episode of Talking DTC with Bob Ehrlich, our founder and chairman and panelists will discuss what can we learn about what works from the successful DTC campaigns. Are there clear “rules” for success?

In this episode of Talking DTC with Bob Ehrlich, our founder and chairman and panelists will discuss health disparities, the growth of non-white demographics, and the emerging business opportunities resulting. What are some “must know” lessons for reaching and engaging our multicultural society?

In this episode of Talking DTC with Bob Ehrlich, our founder and chairman and panelists will discuss print – a still important, but declining, medium. How has the print industry adapted to the decline? What are the opportunities for DTC in magazines and newspapers?

Clinical trial recruiting can make or break your drug approval. Taking a long time to find participants, finding inadequate participants, or not getting the right sample can cost your company millions, if not billions, of dollars. And now, due to recent regulatory rulings, it is imperative that clinical trials include a more representative sample of minorities for a drug to get approved. Our panel of experts discusses the challenges in getting this representative sample of participants in your trial, what are some ways to increase participation, and how companies can improve their communication and recruitment strategies to increase the speed and makeup of their trial participation.

How do DTC advertisers measure success? While ROI may be the bottom line, many metrics may be used to measure consumer response. Measurements are getting more precise and, with so many media vehicles used, more complex. Explore the best ways to set up a measurement system with leading experts.

Clinical trial recruiting can make or break your drug approval. Taking a long time to find participants, finding inadequate participants, or not getting the right sample can cost your company millions, if not billions, of dollars. And now, due to recent regulatory rulings, it is imperative that clinical trials include a more representative sample of minorities for a drug to get approved. Our panel of experts discusses the challenges in getting this representative sample of participants in your trial, what are some ways to increase participation, and how companies can improve their communication and recruitment strategies to increase the speed and makeup of their trial participation.

Point of Care advertising has exploded in importance as every DTC advertiser wants their disease education and brand message to be seen by patients where they get treated. While most POC started as magazines, wallboards, pamphlets, in-office TV ads, the techniques used have evolved with the digital media explosion. Office coverage growth has made POC a national scalable media option. Hear from leading experts what is the future of POC.

Contact John Woodbridge for more information on sponsored virtual speaking opportunities.

Point of Care advertising has exploded in importance as every DTC advertiser wants their disease education and brand message to be seen by patients where they get treated. While most POC started as magazines, wallboards, pamphlets, in-office TV ads, the techniques used have evolved with the digital media explosion. Office coverage growth has made POC a national scalable media option. Hear from leading experts what is the future of POC.

Contact John Woodbridge for more information on sponsored virtual speaking opportunities.

Contact John Woodbridge for more information on sponsored virtual speaking opportunities.

Contact John Woodbridge for more information on sponsored virtual speaking opportunities.